1. Home
  2. R vs COGT Comparison

R vs COGT Comparison

Compare R & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryder System Inc.

R

Ryder System Inc.

HOLD

Current Price

$192.14

Market Cap

6.5B

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$37.95

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
R
COGT
Founded
1933
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
R
COGT
Price
$192.14
$37.95
Analyst Decision
Buy
Buy
Analyst Count
10
13
Target Price
$204.67
$30.17
AVG Volume (30 Days)
335.4K
2.4M
Earning Date
02-11-2026
02-24-2026
Dividend Yield
1.91%
N/A
EPS Growth
10.62
N/A
EPS
11.82
N/A
Revenue
$12,679,000,000.00
N/A
Revenue This Year
$2.54
N/A
Revenue Next Year
$3.74
N/A
P/E Ratio
$16.10
N/A
Revenue Growth
1.68
N/A
52 Week Low
$125.54
$3.72
52 Week High
$200.53
$43.73

Technical Indicators

Market Signals
Indicator
R
COGT
Relative Strength Index (RSI) 54.29 56.87
Support Level $189.37 $33.84
Resistance Level $194.82 $36.88
Average True Range (ATR) 4.53 1.73
MACD -0.88 -0.36
Stochastic Oscillator 49.96 68.41

Price Performance

Historical Comparison
R
COGT

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: